Form 4: Revolution Medicines' COO Margaret Horn Sells Shares to Cover Tax Obligations

Margaret Horn, Chief Operating Officer of Revolution Medicines, sold 2,914 shares of common stock on March 18, 2024, to cover tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).

Summary

• On March 18, 2024, Margaret Horn, the Chief Operating Officer of Revolution Medicines, sold 2,914 shares of the company's common stock.
• The sale was executed at a price of $31.5832 per share.
• This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2023, to cover tax obligations related to the vesting of RSUs.
• The shares were sold automatically to cover applicable withholding taxes as per the terms of the RSU award.
• Following the transaction, Horn directly owns 139,553 shares, which includes 94,150 RSUs.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon RSU vesting are a common practice among corporate executives and are generally viewed as routine.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the routine nature of the transaction.

Key Dates